Author Archives: Johnny

Geroprotective Treatment Human Trial

As associate is opening a private group for those who would like to 1) participate in a geroprotective treatment human trial (if you don’t already take some geroprotective treatments) or 2) contribute in a geroprotective human clinical trial. For details … Continue reading

Posted in Uncategorized | Comments Off

Drug Screening Using Engineered Tissues

There is a tremendous opportunity for drug screening using engineered tissues to create aging solutions. Three articles follow. You are encouraged to send comments directly to me at  JAdams at sign agingintervention dot org or call (949) 922-9786. Artificial Human … Continue reading

Posted in Uncategorized | Comments Off

Tissue Engineering

Exciting uses include engineering of replacement organs, and tissue repair and replacement for problems like degeneration and wound repair. Artificial human tissues could replace animals in drug tests, and tissue engineering can be used in personalized medicine. From NIH Science … Continue reading

Posted in Uncategorized | Comments Off

Practical Methionine Reduction in Humans

Link to the guide Practical Methionine Reduction in Humans is below. It’s under development as new information is located. It offers some basics of why reducing methionine could be useful in slowing aging and increasing years of healthy life, and … Continue reading

Posted in Uncategorized | Comments Off

PAPP-A: A new anti-aging target? Mayo Clinic Email Newsletter

PAPP-A: A new anti-aging target? Mayo Clinic Email Newsletter By Cheryl A. Conover, Ph.D., of the Division of Endocrinology, Diabetes, Metabolism and Nutrition at Mayo Clinic in Rochester, Minn., A few summary points: -        Cheryl A. Conover, Ph.D., strives for … Continue reading

Posted in Uncategorized | Comments Off

Substantial Health And Economic Returns From Delayed Aging May Warrant A New Focus For Medical Research

http://content.healthaffairs.org/content/32/10/1698.abstract Abstract: Recent scientific advances suggest that slowing the aging process (senescence) is now a realistic goal. Yet most medical research remains focused on combating individual diseases. Using the Future Elderly Model, a microsimulation of the future health and spending … Continue reading

Posted in Uncategorized | Comments Off

Biotech industry innovation helps drive advances affecting aging R&D

Potential for Deals Drives a Big Surge in the Biotech Sector Key points — link to article is below: The pharmaceutical industry has been hunting for innovation among small biotechnology companies The feared “patent cliff” for brand-name drugs has caused … Continue reading

Posted in Uncategorized | Comments Off

The Trans-NIH Geroscience Interest Group (GSIG) is making great contributions to our shared purpose

You will find the video near the BOTTOM of the linked page below particularly useful. Title is “Targeting Aging to Delay Multiple Chronic Diseases: A New Frontier”. http://sigs.nih.gov/geroscience/For%20Videos/GSIG%20Videos.aspx   To help you find info that most interests you: Up until … Continue reading

Posted in Uncategorized | Comments Off

Webcast Details — Gerontology Research Group March 1

The meeting officially starts on Friday, March 1st at 8:00 PM PST However, I plan to test and have it going at around 7:30 so feel free to join anytime. GMT Saturday, March 2, 2013 at 4:00:00 AM World time … Continue reading

Posted in Uncategorized | Comments Off

Gerontology Research Group March 1 Meeting Announcement

Our next Gerontology Research Group meeting will be on Friday, March 1st at 8:00 PM PST GMT Saturday, March 2, 2013 at 4:00:00 AM Guest Speakers: Drs. Leonid Gavrilov, Ph.D. (GSA Fellow) and Natalia Gavrilova of the University of Chicago … Continue reading

Posted in Uncategorized | Comments Off